Log in
OTCMKTS:RNVA

Rennova Health Stock Forecast, Price & News

$0.11
+0.01 (+5.00 %)
(As of 10/30/2020 03:39 PM ET)
Add
Compare
Today's Range
$0.09
Now: $0.11
$0.11
50-Day Range
$0.10
MA: $0.19
$0.26
52-Week Range
$0.09
Now: $0.11
$4.00
Volume27,161 shs
Average Volume28,680 shs
Market Capitalization$123,795.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.64
Rennova Health, Inc., together with its subsidiaries, engages in the hospital operations in the United States. It operates in two segments, Hospital Operations and Clinical Laboratory Services. The company provides a suite of healthcare related products and services for healthcare providers, patients, and individuals. It also offers diagnostic imaging, radiology, surgery, nuclear medicine, wound care and hyperbaric medicine, intensive care, emergency care, and physical therapy services; and X-ray, mammography, bone densitometry, computed tomography, ultrasound, physical therapy, and laboratory services. In addition, the company provides blood and urine, toxicology, clinical pharmacogenetics, and esoteric testing services. Further, it invests in and develops a suite of software products to its diagnostics business. Additionally, the company owns three hospitals, a physician's office in Tennessee, and a rural clinic in Kentucky. Rennova Health, Inc. was founded in 2005 and is based in West Palm Beach, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RNVA
Previous SymbolNASDAQ:RNVA
CUSIPN/A
Phone561-855-1626
Employees98

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.99 million
Book Value($79.32) per share

Profitability

Net Income$-48,030,000.00
Net Margins-233.31%

Miscellaneous

Market Cap$123,795.00
Next Earnings Date1/4/2021 (Estimated)
OptionableNot Optionable
$0.11
+0.01 (+5.00 %)
(As of 10/30/2020 03:39 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RNVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RNVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions

How has Rennova Health's stock been impacted by COVID-19 (Coronavirus)?

Rennova Health's stock was trading at $0.0001 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RNVA stock has increased by 104,900.0% and is now trading at $0.1050.
View which stocks have been most impacted by COVID-19
.

When is Rennova Health's next earnings date?

Rennova Health is scheduled to release its next quarterly earnings announcement on Monday, January 4th 2021.
View our earnings forecast for Rennova Health
.

How were Rennova Health's earnings last quarter?

Rennova Health, Inc. (OTCMKTS:RNVA) released its earnings results on Thursday, August, 13th. The company reported ($1.06) earnings per share for the quarter. The company earned $2.07 million during the quarter.
View Rennova Health's earnings history
.

When did Rennova Health's stock split? How did Rennova Health's stock split work?

Shares of Rennova Health reverse split before market open on Monday, November 12th 2018. The 1-500 reverse split was announced on Thursday, November 8th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 9th 2018. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 0 shares after the split.

Are investors shorting Rennova Health?

Rennova Health saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 25,700 shares, an increase of 678.8% from the September 30th total of 3,300 shares. Based on an average daily trading volume, of 210,200 shares, the days-to-cover ratio is presently 0.1 days.
View Rennova Health's Short Interest
.

Who are some of Rennova Health's key competitors?

What other stocks do shareholders of Rennova Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), Precipio (PRPO), CytRx (CYTR), Heat Biologics (HTBX), Biopharmx (BPMX), Delcath Systems (DCTHD), Immune Pharmaceuticals (IMNP), Protalix BioTherapeutics (PLX) and 22nd Century Group (XXII).

Who are Rennova Health's key executives?

Rennova Health's management team includes the following people:
  • Mr. Seamus Lagan, Pres, CEO, Interim CFO & Director (Age 51, Pay $399k)
  • Ms. Karen Taylor, Director of HR
  • Mr. Albert F. Lechner, Exec. VP of Sales - Rennova Health Technology Solutions
  • Mr. Michael Alexander, CEO of Jamestown Medical Center, Inc.
  • Mr. Sebastien Sainsbury, Company Sec. & PR

What is Rennova Health's stock symbol?

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

How do I buy shares of Rennova Health?

Shares of RNVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rennova Health's stock price today?

One share of RNVA stock can currently be purchased for approximately $0.11.

How big of a company is Rennova Health?

Rennova Health has a market capitalization of $123,795.00 and generates $15.99 million in revenue each year. Rennova Health employs 98 workers across the globe.

What is Rennova Health's official website?

The official website for Rennova Health is www.rennovahealth.com.

How can I contact Rennova Health?

Rennova Health's mailing address is 931 Village Boulevard Suite 905, West Palm Beach FL, 33409. The company can be reached via phone at 561-855-1626 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.